Guangzhou Lerui Biotechnology Co., Ltd. – Trademark Portfolio
Entity Type: 16
Guangzhou Lerui Biotechnology Co., Ltd. has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 100% registration rate. The portfolio includes marks such as QPETAL. Filings span 3 Nice Classification classes, with the highest activity in Class 10 (Medical Apparatus) and Class 16 (Paper Goods). This trademark owner is based in Guangzhou.
Room 917, No. 8 Yuanjing Road, Tianhe District
Guangzhou 510000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangzhou Lerui Biotechnology Co., Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Guangzhou Lerui Biotechnology Co., Ltd. have?
Guangzhou Lerui Biotechnology Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Guangzhou Lerui Biotechnology Co., Ltd. file in?
Guangzhou Lerui Biotechnology Co., Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 16 (Paper Goods), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Guangzhou Lerui Biotechnology Co., Ltd.'s most well-known trademarks?
Guangzhou Lerui Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as QPETAL. These are among 2 currently registered trademarks in the portfolio.
What is Guangzhou Lerui Biotechnology Co., Ltd.'s trademark registration success rate?
Guangzhou Lerui Biotechnology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.